Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Efficacy and weight loss outcomes Clinical trials demonstrate distinct results: Zepbound : Participants lost 20.2% of body weight on average (50.3 lbs) over 72 weeks in SURMOUNT-5 trials
The July 2026 FDA PCAC review also shows that Epitalon remains part of an active regulatory conversation around compounded peptide access
Safety Note: If you ever experience sudden swelling in the neck, difficulty swallowing, persistent hoarseness, or a visible lump in the throat area, you must seek urgent medical attention through your GP or A&E
For BMI above 40, comparison between GLP-1 therapy and bariatric surgery involves weighing multiple factors including health status, personal preferences, and long-term management considerations
US$ 27.19
US$ 20.10
US$ 28.26
US$ 27.25
US$ 27.15
